Immediate Impact
51 standout
Citing Papers
Reactive oxygen species in hypertension
2024 Standout
Long COVID: a clinical update
2024 Standout
Works of Amy Rogers being referenced
Adverse events and overall health and well-being after COVID-19 vaccination: interim results from the VAC4COVID cohort safety study
2022
Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial
2022
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Amy Rogers | 157 | 139 | 134 | 45 | 760 | |
| Joana Alarcão | 87 | 51 | 161 | 32 | 720 | |
| Tracy Wolff | 199 | 150 | 186 | 23 | 905 | |
| Tatsuya Noda | 120 | 136 | 82 | 81 | 806 | |
| Stephanie L. Filipp | 86 | 142 | 191 | 59 | 957 | |
| Mikael Hoffmann | 106 | 104 | 156 | 49 | 934 | |
| Gian Paolo Morgano | 216 | 65 | 94 | 27 | 874 | |
| Carla Fornari | 139 | 83 | 66 | 63 | 711 | |
| Kay M. Johnson | 50 | 139 | 107 | 37 | 866 | |
| Brian H Willis | 56 | 59 | 126 | 36 | 831 | |
| Clare Clement | 64 | 102 | 93 | 38 | 764 |
All Works
Login with ORCID to disown or claim papers
Loading papers...